Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 23,399 | 50,193 | 117,641 | 87,880 |
| Marketable securities | 252,903 | 285,884 | 258,162 | 205,047 |
| Intangible assets, net | NaN | NaN | 135,255 | 131,060 |
| Trade accounts receivable, net of allowance for credit losses of 21,420 as of march 31, 2026, and 21,411 as of december 31, 2025 | 69,277 | 84,762 | 71,187 | 77,190 |
| Prepaid income taxes | 109,165 | 107,099 | NaN | NaN |
| Other current assets | 24,298 | 22,552 | 60,384 | 58,610 |
| Total current assets | 479,042 | 550,490 | 507,374 | 428,727 |
| Marketable securities, long-term | 328,287 | 369,269 | 411,778 | 484,471 |
| Fixed assets, gross | 177,653 | 170,494 | 166,064 | NaN |
| Less accumulated depreciation | 61,309 | 57,945 | 54,199 | NaN |
| Fixed assets, net | 116,344 | 112,549 | 111,865 | 110,223 |
| Acquisitions-related intangibles, net | 68,490 | 68,490 | NaN | NaN |
| Other intangible assets, net | 85,499 | 64,791 | NaN | NaN |
| Goodwill | 53,731 | 25,080 | 25,080 | 22,055 |
| Other long-term assets | 24,976 | 22,856 | 23,211 | 23,302 |
| Total assets | 1,156,369 | 1,213,525 | 1,214,563 | 1,199,838 |
| Accounts payable | 21,125 | 18,654 | 18,088 | 18,887 |
| Accrued liabilities | 34,901 | 34,057 | 23,010 | 21,699 |
| Customer deposit | 30,619 | 28,145 | 28,543 | 27,600 |
| Contract liabilities | 3,007 | 3,635 | 2,309 | 2,673 |
| Notes payable, current | 482 | 476 | 476 | 476 |
| Total current liabilities | 90,134 | 84,967 | 72,426 | 71,335 |
| Deferred tax liabilities | 6,982 | 6,936 | 7,040 | 6,124 |
| Unrecognized tax benefits | 5,727 | 7,283 | 6,783 | 4,838 |
| Other long-term liabilities | 9,372 | 7,624 | 7,557 | 5,905 |
| Total liabilities | 112,215 | 106,810 | 93,806 | 88,202 |
| Common stock, 0.0001 par value per share, 50,000 shares authorized, 34,870 shares issued and 28,851 shares outstanding as of march 31, 2026, and 34,501 shares issued and 31,081 shares outstanding as of december 31, 2025 | 4 | 3 | 3 | 3 |
| Additional paid-in capital | 540,141 | 574,520 | 565,690 | 550,599 |
| Accumulated other comprehensive income (loss) | 4,536 | 7,512 | 6,823 | 5,998 |
| Retained earnings | 505,128 | 529,954 | 553,372 | 559,980 |
| Total fulgent stockholders' equity | 1,049,809 | 1,111,989 | 1,125,888 | 1,116,580 |
| Noncontrolling interest | -5,655 | -5,274 | -5,131 | -4,944 |
| Total stockholders equity | 1,044,154 | 1,106,715 | 1,120,757 | 1,111,636 |
| Total liabilities and stockholders equity | 1,156,369 | 1,213,525 | 1,214,563 | 1,199,838 |